Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phil Lieberman

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Allergy and Asthma Proceedings|November 7, 2012
Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitisWarner W Carr, Paul Ratner, Ullrich Munzel, et al.
The World Allergy Organization Journal|November 16, 2013
Consensus Definition of Nonallergic Rhinopathy, Previously Referred to as Vasomotor Rhinitis, Nonallergic Rhinitis, and/or Idiopathic RhinitisMichael A Kaliner, James N Baraniuk, Michael Benninger, et al.
The World Allergy Organization Journal|November 16, 2013
Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic RhinitisMichael A Kaliner, James N Baraniuk, Michael S Benninger, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 1, 2011
Suggested updated approaches to patient managementRohit K Katial, Eli O Meltzer, Phil Lieberman, et al.
Expert Review of Clinical Immunology|September 2, 2015
Current controversies and challenges in allergic rhinitis managementDavid Price, Pete Smith, Peter Hellings, et al.
Expert Opinion on Pharmacotherapy|March 10, 2015
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gapsJean Bousquet, Claus Bachert, Jonathan Bernstein, et al.
International Archives of Allergy and Immunology|May 9, 2013
Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysisEli Meltzer, Paul Ratner, Claus Bachert, et al.
The World Allergy Organization Journal|June 13, 2014
International consensus on (ICON) anaphylaxisF Estelle R Simons, Ledit Rf Ardusso, M Beatrice Bilò, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 13, 2017
Sublingual immunotherapy: A focused allergen immunotherapy practice parameter updateMatthew Greenhawt, John Oppenheimer, Michael Nelson, et al.
Nutrition Research (New York, N.Y.)|February 12, 2011
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel reportJoshua A Boyce, Amal Assa'ad, A Wesley Burks, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Allergy and Asthma Proceedings|November 7, 2012
Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitisWarner W Carr, Paul Ratner, Ullrich Munzel, et al.
The World Allergy Organization Journal|November 16, 2013
Consensus Definition of Nonallergic Rhinopathy, Previously Referred to as Vasomotor Rhinitis, Nonallergic Rhinitis, and/or Idiopathic RhinitisMichael A Kaliner, James N Baraniuk, Michael Benninger, et al.
The World Allergy Organization Journal|November 16, 2013
Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic RhinitisMichael A Kaliner, James N Baraniuk, Michael S Benninger, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 1, 2011
Suggested updated approaches to patient managementRohit K Katial, Eli O Meltzer, Phil Lieberman, et al.
Expert Review of Clinical Immunology|September 2, 2015
Current controversies and challenges in allergic rhinitis managementDavid Price, Pete Smith, Peter Hellings, et al.
Expert Opinion on Pharmacotherapy|March 10, 2015
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gapsJean Bousquet, Claus Bachert, Jonathan Bernstein, et al.
International Archives of Allergy and Immunology|May 9, 2013
Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysisEli Meltzer, Paul Ratner, Claus Bachert, et al.
The World Allergy Organization Journal|June 13, 2014
International consensus on (ICON) anaphylaxisF Estelle R Simons, Ledit Rf Ardusso, M Beatrice Bilò, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 13, 2017
Sublingual immunotherapy: A focused allergen immunotherapy practice parameter updateMatthew Greenhawt, John Oppenheimer, Michael Nelson, et al.
Nutrition Research (New York, N.Y.)|February 12, 2011
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel reportJoshua A Boyce, Amal Assa'ad, A Wesley Burks, et al.
Pageof 6